Nanobiotechnology for dendritic cell-based cancer immunotherapy
Cell Biomaterials · 2026-05 · 100485
DOI: 10.1016/j.celbio.2026.100485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biomaterials, 2026-05. Verfasst von Rongzhang Li und 6 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 374 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Academy of Sciences, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
- Chinese Academy of Sciences
- Science and Technology Commission of Shanghai Municipality
- Ministry of Science and Technology of the People's Republic of China
- National Key Research and Development Program of China
Zitieren
APA
Li, R., Yi, W., Qian, X., Hu, S., Shen, H., Yan, D., & Li, Y. (2026). Nanobiotechnology for dendritic cell-based cancer immunotherapy. Cell Biomaterials, 100485. https://doi.org/10.1016/j.celbio.2026.100485
Vancouver
Li R, Yi W, Qian X, Hu S, Shen H, Yan D, et al. Nanobiotechnology for dendritic cell-based cancer immunotherapy. Cell Biomaterials. 2026:100485. doi:10.1016/j.celbio.2026.100485
BibTeX
@article{Li2026,
author = {Li, Rongzhang and Yi, Wenzhe and Qian, Xindi and Hu, Shuangshuang and Shen, Honggang and Yan, Dan and Li, Yaping},
title = {Nanobiotechnology for dendritic cell-based cancer immunotherapy},
journal = {Cell Biomaterials},
year = {2026},
pages = {100485},
doi = {10.1016/j.celbio.2026.100485}
}
EUVIMED